A Cross-sectional study, whether parathyroid hormone (PTH) correlates with pulmonary hypertension.
Not Applicable
- Conditions
- pulmonary hypertension
- Registration Number
- JPRN-UMIN000050461
- Lead Sponsor
- Juntendo University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria are under 18 year old, chronic renal disease (eGFR<50), left heart diseases (group2 PH), past history with cancer and treated with drugs influence for bone metabolism.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.age,sex,diagnosis 2.serological tests (with intact PTH) 3.UCG 4.right heart hemodynamics by catheter
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Does parathyroid hormone (PTH) correlate with pulmonary arterial pressure in patients with pulmonary hypertension?
What molecular mechanisms link elevated PTH levels to the development of pulmonary hypertension?
Are there specific biomarkers that indicate PTH's role in pulmonary hypertension progression?
How does PTH influence right ventricular function in individuals with pulmonary hypertension?
Can PTH serve as a predictive marker for treatment response in pulmonary hypertension therapies?